
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Innovator IBD 50 ETF (ARCA:FFTY) through any online brokerage.
There are no as such competitors for Innovator IBD 50 ETF.
There is no analysis for Innovator IBD 50 ETF to provide a consensus price target.
The stock price for Innovator IBD 50 ETF (ARCA: FFTY) is $ last updated .
There are no upcoming dividends for Innovator IBD 50 ETF.
Innovator IBD 50 ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Innovator IBD 50 ETF.
| Sector | Healthcare |
| Category | High Performer-High Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | Apr 8, 2015 |
| Managers | Anand Desai Ernesto Tong Dustin Lewellyn |
| Definition | An equity fund portfolio full of stocks with both strong financial performance and superior growth potential |
| Symbol | Name | Share % |
|---|---|---|
| TVTX | Travere Therapeutics I... | 3.68% |
| CA | Iamgold Corp | 3.40% |
| STOK | Stoke Therapeuti | 3.41% |
| ARQT | Arcutis Biotherapeutic... | 3.62% |
| MU | Micron Technology, Inc | 3.78% |
| PACS | Pacs Group Inc | 3.53% |
| ANAB | Anaptysbio Inc | 3.27% |
| RKLB | Rocket Lab Corp | 3.78% |
| CDE | Coeur Mining Inc | 3.40% |
| DY | Dycom Industries Inc_N... | 3.05% |